Evotec and Indivumed achieve milestone in joint strategic drug discovery collaboration

  • Evotec SE and Indivumed GmbH announced today that the first milestone has been successfully achieved in their joint collaboration to identify new therapeutic targets for the treatment of colorectal cancer. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-indivumed-achieve-milestone-in-joint-strategic-drug-discovery-collaboration-5849

    Du magst vielleicht auch